Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid
US11129877B2 · kind B2 · utility
0Cited by
6References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2018 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Dec 7, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G69/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition in the form of an injectable aqueous solution, for which the pH is comprised from 6.0 to 8.0, includes at least: characterized in that the composition does not include basal insulin for which the isoelectric point IP is comprised from 5.8 to 8.5. The composition also includes a prandial insulin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.